CROCS INC (CROX)
US2270461096 - Common Stock
CROX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 51 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX has an excellent profitability rating, but there are some minor concerns on its financial health. CROX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CROX had positive earnings in the past year.
In the past year CROX had a positive cash flow from operations.
CROX had positive earnings in each of the past 5 years.
In the past 5 years CROX always reported a positive cash flow from operatings.
1.2 Ratios
CROX has a better Return On Assets (16.59%) than 96.00% of its industry peers.
CROX's Return On Equity of 49.81% is amongst the best of the industry. CROX outperforms 98.00% of its industry peers.
With an excellent Return On Invested Capital value of 21.10%, CROX belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CROX is significantly above the industry average of 10.06%.
The 3 year average ROIC (30.08%) for CROX is well above the current ROIC(21.10%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.59% | ||
| ROE | 49.81% | ||
| ROIC | 21.1% |
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%
1.3 Margins
The Profit Margin of CROX (19.80%) is better than 100.00% of its industry peers.
CROX's Profit Margin has declined in the last couple of years.
CROX's Operating Margin of 26.43% is amongst the best of the industry. CROX outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
With a decent Gross Margin value of 56.16%, CROX is doing good in the industry, outperforming 72.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CROX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.43% | ||
| PM (TTM) | 19.8% | ||
| GM | 56.16% |
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%
2. Health
2.1 Basic Checks
CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CROX has been reduced compared to 1 year ago.
CROX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CROX has been reduced compared to a year ago.
2.2 Solvency
CROX has an Altman-Z score of 4.11. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
CROX has a better Altman-Z score (4.11) than 70.00% of its industry peers.
CROX has a debt to FCF ratio of 2.19. This is a good value and a sign of high solvency as CROX would need 2.19 years to pay back of all of its debts.
CROX has a Debt to FCF ratio of 2.19. This is comparable to the rest of the industry: CROX outperforms 60.00% of its industry peers.
CROX has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CROX (1.08) is worse than 80.00% of its industry peers.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | 2.19 | ||
| Altman-Z | 4.11 |
ROIC/WACC2.29
WACC9.2%
2.3 Liquidity
CROX has a Current Ratio of 1.76. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CROX (1.76) is worse than 66.00% of its industry peers.
CROX has a Quick Ratio of 1.14. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.14, CROX is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.46% over the past year.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.01% on average per year.
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.29%.
Measured over the past years, CROX shows a very strong growth in Revenue. The Revenue has been growing by 29.49% on average per year.
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5YN/A
EPS growth Q2Q15.71%
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Revenue growth Q2Q6.16%
3.2 Future
Based on estimates for the next years, CROX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.49% on average per year.
CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.26% yearly.
EPS Next Y5.59%
EPS Next 2Y7.43%
EPS Next 3Y7.86%
EPS Next 5Y8.49%
Revenue Next Year4.18%
Revenue Next 2Y4.79%
Revenue Next 3Y4.94%
Revenue Next 5Y7.26%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CROX is valuated reasonably with a Price/Earnings ratio of 11.33.
82.00% of the companies in the same industry are more expensive than CROX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CROX to the average of the S&P500 Index (28.15), we can say CROX is valued rather cheaply.
With a Price/Forward Earnings ratio of 10.15, the valuation of CROX can be described as very reasonable.
88.00% of the companies in the same industry are more expensive than CROX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.20. CROX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.33 | ||
| Fwd PE | 10.15 |
4.2 Price Multiples
CROX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CROX is cheaper than 66.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CROX is valued a bit cheaper than the industry average as 64.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.84 | ||
| EV/EBITDA | 9.1 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CROX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)2.03
PEG (5Y)N/A
EPS Next 2Y7.43%
EPS Next 3Y7.86%
5. Dividend
5.1 Amount
No dividends for CROX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CROCS INC
NASDAQ:CROX (5/17/2024, 7:00:01 PM)
After market: 140.95 0 (0%)140.95
-1.06 (-0.75%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.56B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.33 | ||
| Fwd PE | 10.15 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.03
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.59% | ||
| ROE | 49.81% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 26.43% | ||
| PM (TTM) | 19.8% | ||
| GM | 56.16% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5Y
EPS growth Q2Q
EPS Next Y5.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y